Cases & Deals

  • Home
  • Practices
  • Cardinal Health acquires The Harvard Drug Group for $1.115 billion

Share

Cardinal Health acquires The Harvard Drug Group for $1.115 billion

July 2015

Client(s) Cardinal Health, Inc.

Jones Day advised Cardinal Health in its acquisition of The Harvard Drug Group, a distributor of generic pharmaceuticals, over-the-counter medications, and related products to retail, institutional, and alternate care customers from Court Square Capital Partners for $1.115 billion.

In addition to M&A representation, Jones Day provided health care, employee benefits, intellectual property, and antitrust advice regarding this transaction.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.